In addition, the SLC2A5 gene and its encodingGLUT5 are upregulated in malignant tumors such as prostate cancer, breast cancer, acutemyeloid leukemia and clear cell renal cell carcinoma and promote tumor progression [ 136– 139]. The gene discussed is SLC2A5; the disease is prostate carcinoma.